Krognes Steve E.
- SEC CIK
- 0001666236
In the past year, 2 open-market sale filings worth $2.40M and no purchases.
Current role at each company
- GH Guardant Health, Inc.Directoras of Sep 17, 2026
- PLRX Pliant Therapeutics, Inc.Directoras of Jun 12, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jun 5, 2026
- CIK 0001656634Directoras of Jun 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.40M
- 2 filings
- Net
- −$2.40M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Krognes Steve E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GH Guardant Health, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)5:10 PM ET | Sep 16 | 1 day | Krognes Steve E.Director | SSale | −6.67K | $175.74 | −$1.17M | −45.8%7.91K after | 4 lots |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Krognes Steve E.Director | SSale | −9.29K | $132.51 | −$1.23M | −47.6%10.2K after |
DNLI Denali Therapeutics Inc.
Director17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 (view filing) | Jan 7 | 1 day | Krognes Steve E.Director | SSale | −3.34K | $20.81 | −$69.5K | −11.5%25.8K after | |
| Jan 3, 2025 (view filing) | Dec 31, 2024 | 3 days | Krognes Steve E.Director | SSale | −30.0K | $20.25 | −$607.5K | −50.8%29.1K after | 10b5-1 |
| Oct 2, 2024 (view filing) | Sep 30 | 2 days | Krognes Steve E.Director | SSale | −30.0K | $29.03 | −$870.9K | −50.8%29.1K after | 10b5-1 |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Krognes Steve E.Director | SSale | −1.73K | $23.79 | −$41.1K | −5.0%32.7K after | |
| Jul 3, 2024 (view filing) | Jun 13-Jul 1 | 20 daysLate | Krognes Steve E.Director | SSale | −30.7K | $22.11 | −$678.7K | −47.1%34.4K after | 3 lots10b5-1 |
| Apr 2, 2024 (view filing) | Apr 1 | 1 day | Krognes Steve E.Director | SSale | −92.5K | $20.50 | −$1.90M | −66.1%47.3K after | 10b5-1 |
| Feb 15, 2024 (view filing) | Feb 13 | 2 days | Krognes Steve E.Director | SSale | −2.75K | $17.29 | −$47.5K | −1.9%139.8K after | |
| Jan 9, 2024 (view filing) | Jan 5 | 4 days | Krognes Steve E.Director | SSale | −3.21K | $19.43 | −$62.3K | −2.2%142.6K after | |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Krognes Steve E.Director | SSale | −1.42K | $22.60 | −$32.1K | −1.0%145.8K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Krognes Steve E.Director | SSale | −2.12K | $30.10 | −$63.8K | −1.5%143.0K after |